Baldingerstraße 01
35043 Marburg
Phone:
06421-58-60
Fax:
06421-58-66370
Mail:
ed.mg-ku@rm.fgea
Bezeichnung | |
Teilnahme externe Qualitätssicherung | yes |
Bezeichnung | |
Teilnahme externe Qualitätssicherung | yes |
Bezeichnung | |
Teilnahme externe Qualitätssicherung | no |
Quantity performed | 39 |
Exception? | No exception |
Quantity performed | 29 |
Exception? | No exception |
Quantity performed | 56 |
Exception? | No exception |
Quantity performed | 25 |
Exception? | No exception |
Quantity performed | 90 |
Exception? | No exception |
Quantity performed | 24 |
Exception? | No exception |
Quantity performed | 1 |
Exception? | No exception |
Overall result forecast presentation: | Pending lawsuit |
Quantity performed reporting year: | 39 |
Quantity forecast year: | 39 |
Examination by state associations? | Pending lawsuit |
Exemption? | yes |
Result of the examination by the federal state authorities? | no |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 29 |
Quantity forecast year: | 32 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 56 |
Quantity forecast year: | 53 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 25 |
Quantity forecast year: | 31 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 90 |
Quantity forecast year: | 128 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
Overall result forecast presentation: | Pending lawsuit |
Quantity performed reporting year: | 24 |
Quantity forecast year: | 22 |
Examination by state associations? | Pending lawsuit |
Exemption? | yes |
Result of the examination by the federal state authorities? | no |
Transitional arrangement? | no |
Overall result forecast presentation: | no |
Quantity performed reporting year: | 1 |
Quantity forecast year: | 0 |
Examination by state associations? | no |
Exemption? | no |
Result of the examination by the federal state authorities? | no |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 625 |
Quantity forecast year: | 585 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 52 |
Quantity forecast year: | 79 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
No. | Explanation |
---|---|
CQ01 | Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm |
CQ03 | Quality assurance measures for the implementation of positron emission tomography (PET) in hospitals for the indications non-small-cell lung cancer (NSCLC) and solid pulmonary nodules |
CQ05 | Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1 |
CQ24 | Quality assurance measures for allogeneic stem cell transplantation for multiple myeloma (valid until 30 June 2022) |
CQ25 | Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V |
CQ27 | Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR) |
CQ30 | Quality assurance guideline for interstitial LDR brachytherapy for low-risk localized prostate cancer (effective January 8, 2021). |
Number | Group |
---|---|
363 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
228 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
225 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.
Information gathering on the topic
Training of employees
Education
In den Klinischen Strategischen Zielen des UKGM in Marburg wird im Absatz 1 "Patientensicherheit" der Schutz von Minderjährigen explizit festgelegt.
Special requirements for the selection of persons
Other aspects of intervention
https://insight.rka/fileadmin/100_RKA/199_Microsites/Compliance/Haltungsgrundsaetze/B_Haltungsgrundsaetze_web.pdf
Training of employees on AMTS related topics
Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children
Qualitätsmanagement Konzept Rhönklinikum AG. Für alle Standorte des Universitätsklinikums Gießen und Marburg in Marburg sind Vorgabedokumente zu QM-Prozessen und Dokumente für das Risikomanagement jederzeit verfügbar.
09.11.2022
Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)
Qualitätsmanagement Konzept Rhönklinikum AG. Für alle Standorte des Universitätsklinikums Gießen und Marburg in Marburg sind Vorgabedokumente zu QM-Prozessen und Dokumente für das Risikomanagement jederzeit verfügbar.
09.11.2022
Gute Verordnungspraxis
09.09.2020
Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)
Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)
Electronic documentation of the administration of drugs
FL01 - Lectureships / teaching posts at colleges and universities
FL03 - Student training (clinical traineeship / internship year)
FL04 - Project-related cooperation with colleges and universities
FL05 - Participation in multi-centre Phase I/II studies
FL06 - Participation in multi-centre phase III/IV studies
FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies
FL08 - Editors of scientific journals/textbooks
FL09 - Doctoral supervision
HB15 - Anaesthesia technical assistant (m/f)
die praktische Ausbildung findet auch am Klinikum statt.
HB02 - Health and paediatric nurse (m/f)
HB01 - Nurse and health care worker (m/f)
HB10 - Midwife (m/f)
HB03 - Physical therapist / physiotherapist (m/f)
In Kooperation mit der DRK Schwesternschaft Marburg wird eine Krankenpflegehilfeausbildung angeboten. Die Ausbildung ist AZAV zertifiziert.
HB09 - Speech therapist (m/f)
HB13 - Medical technical assistant for functional diagnostics (MTAF) (m/f)
HB12 - Medical technical laboratory assistant (MTLA) (m/f)
HB05 - Medical technical radiology assistant (MTRA) (m/f)
HB07 - Surgical technical assistant (m/f)
die praktische Ausbildung findet auch am Klinikum statt.
HB19 - Nursing professionals
HB20 - Nursing professional B. Sc.
Frau Cornelia Opitz
Patientenfürsprecherin im Universitätsklinikum MR
Baldingerstraße 01
35043 Marburg
Phone:
0176
-47754425-
Mail:
ed.xmg@ztipo.oc
Frau Anette Wetterau-Ruppersberg
Patientenfürsprecherin (Vertretung)
Baldingerstraße 01
35043 Marburg
Phone:
0171
-9000900-
Mail:
ed.enilno-t@ehceukdlaW
Dr. Theresia Jacobi
Patientenfürsprecherin
Baldingerstraße 01
35043 Marburg
Phone:
06421
-164319-
Mail:
ed.jtrd@ibocaj.aisereht
Thomas Komm
Patientenfürsprecher
Baldingerstraße 01
35043 Marburg
Phone:
06421
-360341-
Mail:
ed.xmg@mmok.samoht
Frau Annegret Platt
Ärztliche Geschäftsführung
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-66101
Mail:
ed.mg-ku@tnemeganamedrewhcseB
Frau Margitta Zeuner
Qualitätsmanagementbeauftragte
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-64502
Mail:
ed.mg-ku@renueZ.attigraM
Prof. Dr. Thomas Wündisch
Ärztlicher Direktor
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-63900
Mail:
ed.mg-ku@hcsidneuW.samohT
Prof. Dr. Thomas Wündisch
Ärztlicher Direktor
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-63900
Mail:
ed.mg-ku@hcsidneuW.samohT
Prof. Dr. med Thomas Wündisch
Ärztlicher Direktor
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-63900
Mail:
ed.mg-ku@hcsidneuw.samoht
Prof. Dr. med Thomas Wündisch
Ärztlicher Direktor
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-63900
Mail:
ed.mg-ku@hcsidneuw.samoht
Frau Annegret Platt
Beschwerdestelle Ärztliche Geschäftsführung
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-66101
Mail:
ed.mg-ku@tnemeganamedrewhcseb
Phone:
06421-58-60
Fax:
06421-58-66370
Mail:
ed.mg-ku@rm.fgea
Jürgen Kleinschmidt
Pflegedirektor ab 2023
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-66391
Mail:
ed.mg-ku@tdimhcsnielk.negreuj
Herr Michael Reinecke
Pflegedirektor
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-66390
Mail:
ed.mg-ku@ekcenieR.leahciM
Jürgen Kleinschmidt
Pflegedirektor ab 2023
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-66391
Mail:
ed.mg-ku@tdimhcsnielk.negreuj
Herr Kevin Pfaffner
Verwaltungsleiter
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-63524
Mail:
ed.mg-ku@renffafp.nivek
Prof. Dr. Uwe Wagner
Ärztlicher Geschäftsführer am Standort Marburg
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-66210
Mail:
ed.mg-ku@rengaw.ewu
Prof. Dr. med Thomas Wündisch
Ärztlicher Direktor ab 2023
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-
Mail:
ed.mg-ku@hcsidneuw.samoht
Prof. Rita Engenhart-Cabillic
Ärztliche Direktorin bis Anfang 2023
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-
Mail:
ed.mg-ku@trahnegne.atir
Prof. Dr. med Thomas Wündisch
Ärztlicher Direktor ab 2023
Baldingerstraße 01
35043 Marburg
Phone:
06421
-58-
Mail:
ed.mg-ku@hcsidneuw.samoht
IK: 260620431
Location number: 773132000
Old location number: 773132000